1999
DOI: 10.1016/s0360-3016(98)00431-3
|View full text |Cite
|
Sign up to set email alerts
|

Postoperative irradiation of pterygium with 90Sr eye applicator

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
20
0
5

Year Published

2001
2001
2023
2023

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 34 publications
(26 citation statements)
references
References 10 publications
1
20
0
5
Order By: Relevance
“…[60][61][62] Petrovich et al 63 described the histologic appearance of enucleated eyes with choroidal melanoma that had been treated with plaque brachytherapy. Scleral atrophy was seen in 33% of post-plaque eyes.…”
Section: Scleral Necrosismentioning
confidence: 99%
“…[60][61][62] Petrovich et al 63 described the histologic appearance of enucleated eyes with choroidal melanoma that had been treated with plaque brachytherapy. Scleral atrophy was seen in 33% of post-plaque eyes.…”
Section: Scleral Necrosismentioning
confidence: 99%
“…The proliferating tissue is characterized by chronic inflammation, proliferating cells, connective tissue remodeling and angiogenesis [5]. The initial treatment of choice was until a few years ago microsurgical (so-called bare sclera) excision but the recurrence rate after excision alone has been reported to be up to 40% [9]. New surgical procedures like free conjunctival autograft are used to reduce the local recurrence rate [4,19].…”
Section: Introductionmentioning
confidence: 99%
“…Pterygium is a benign disease, treated by excision of the affected part of the sclera. Postoperative irradiation of this area reduces the recurrence from 20-40% to less than 5% [25]. In the Netherlands and Belgium this indication most frequently occurs in patients who have been exposed to a large amount of UV radiation (often during presence close to the equator).…”
Section: Pterygiummentioning
confidence: 99%
“…A change of 0.1 mm in radial source positioning causes dose differences in the order of 10%. 2) Relatively little is known about the minimum absorbed dose needed to achieve local control in the three applications of beta sources: in-stent restenosis [16], pterygium [25] and eye melanoma. The clinical results, however, show relatively high local control rates.…”
Section: Considerations For Detector Selection Criteriamentioning
confidence: 99%
See 1 more Smart Citation